Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

FIELD: medicine.SUBSTANCE: group of inventions relates to field of laboratory diagnostics and can be used for estimating changeability of glucose content in blood (GCB), which is one of the most important parameters of controlled diabetes treatment. Method of measuring GCB changeability includes collecting multitude of points of GCB data and their conversion into symmetric interval; determination of zone of risk by GCB, left branch of zone of risk by GCB, showing risk of hypoglycemia, and right branch of zone of risk by GCB, showing risk of hyperglycemia; calculation of maximal value of hypoglycemia risk (LR) and maximal value of hyperglycemia risk (HR); calculation of day mean value of risk zone (DMVRZ):, where multitude of points of data about GCB are collected on i-th day, where i=1, 2,?, M; DMVRZ classification by risk categories and presentation of DMVRZ and classification result. Group of inventions also relate to system of measuring. Changeability of glucose content in blood, which contains unit of GCB data collection, device for data processing, programmed for claimed method realisation and presentation unit.EFFECT: group of inventions ensures obtaining general picture of changeability of glucose content in blood with high degree of reliability and accuracy.28 cl, 13 dwg, 6 tbl, 3 ex


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Mar 10, 2013
  • Application: Jan 5, 2007
    RU RU 2008132137 A
  • Priority: Jan 5, 2007
    US US 2007/0000370 W
  • Priority: Mar 29, 2006
    US US 78694406 P
  • Priority: Jan 5, 2006
    US US 75634006 P

Download Citation


Sign in to the Lens

Feedback